… thrombocytopenia. In this review we discuss the epidemiology, aetiology and management
of thrombotic … We consider the impact of ITP therapies on the increased thrombotic risk, in …

… ‘immune thrombocytopenia,’ ‘idiopathic thrombocytopenic purpura,’ ‘thrombocytopenia,’ ‘immune
thrombocytopenic … Mild headache, thrombocytosis, thrombosis, and reversible increase …

… A further 319 patients were initially diagnosed with another thrombocytopenic condition, of
whom … with Evans syndrome, and in those with increased risks or rates of thrombosis Table 1 . …

… were suspended because of thrombosis reports due to platelet activation by the engagement
of CD154 (CD40L) expressed on their membrane. To avoid thrombosis issues, new anti-…

… Other clinically significant concerns include complications from internal bleeding and an
elevated risk of thrombosis and thromboembolism (13). Management depends on severity of …

… Immune thrombocytopenic purpura (ITP), also known as idiopathic thrombocytopenic
purpura, is a blood disorder in which the body immune system destroys platelets, leading to low …

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by an isolated
decrease in the platelet count and an increased risk of bleeding. The pathogenesis is complex, …

… autoimmune illness known as immune thrombocytopenia, which can affect both adults and
children. Immune thrombocytopenia … of other causes of thrombocytopenia. The lack of a valid …

… hematological disorders, which can initially occur with isolated thrombocytopenia (eg,
thrombotic microangiopathies, congenital thrombocytopenia, and acute leukemia). In selected …

… [19] have emphasized the reduced thrombotic risk in patients treated with fostamatinib …
understood if we put it into perspective. Indeed, the actual risk of thrombosis in ITP is still debated …